REPLIGEN CORP Increase (Decrease) in Other Noncurrent Liabilities
REPLIGEN CORP (RGEN) reported Increase (Decrease) in Other Noncurrent Liabilities of $1.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-07-29
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $221.00K.
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $1.27M, a 167.16% increase year-over-year.
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$2.45M, a 144.89% decline year-over-year.
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $637.00K.
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$1.56M, a 129.30% decline from fiscal 2024.
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for fiscal 2024 was $5.32M, a 6016.09% increase from fiscal 2023.
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for fiscal 2023 was $87.00K, a 90.99% decline from fiscal 2022.
- REPLIGEN CORP increase (decrease) in other noncurrent liabilities for fiscal 2022 was $966.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 3 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.49M 10-Q · filed 2026-07-29 | -$962.00K derived: sum of 3 quarters · filed 2026-07-29 | -$325.00K derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-06 | -$1.18M derived: sum of 2 quarters · filed 2026-05-06 | -$546.00K derived: sum of 3 quarters · filed 2026-05-06 | -$765.00K derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-12-31 | -$2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.81M derived: sum of 2 quarters · filed 2026-02-26 | -$2.03M derived: sum of 3 quarters · filed 2026-07-29 | -$1.56M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $418.00K derived: sum of 2 quarters · filed 2026-07-29 | $893.00K 10-Q · filed 2025-11-04 | $6.36M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-06-30 | -$219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $256.00K 10-Q · filed 2026-07-29 | $5.72M derived: sum of 3 quarters · filed 2026-07-29 | $5.68M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-03-31 | $475.00K 10-Q · filed 2026-05-06 | $5.94M derived: sum of 2 quarters · filed 2026-05-06 | $5.90M derived: sum of 3 quarters · filed 2026-05-06 | $5.94M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.42M derived: sum of 2 quarters · filed 2026-02-26 | $5.47M derived: sum of 3 quarters · filed 2026-02-26 | $5.32M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.00K derived: sum of 2 quarters · filed 2025-11-04 | -$141.00K 10-Q · filed 2025-11-04 | -$133.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$101.00K 10-Q · filed 2025-08-07 | -$93.00K derived: sum of 3 quarters · filed 2026-02-26 | -$168.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$148.00K 10-Q · filed 2025-04-29 | -$140.00K derived: sum of 2 quarters · filed 2026-02-26 | -$215.00K derived: sum of 3 quarters · filed 2026-02-26 | -$4.87M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | -$67.00K derived: sum of 2 quarters · filed 2026-02-26 | -$4.72M derived: sum of 3 quarters · filed 2026-02-26 | $87.00K 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$75.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$4.73M derived: sum of 2 quarters · filed 2024-11-18 | $79.00K 10-Q/A · filed 2024-11-18 | $1.42M derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2023-06-30 | -$4.66M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $154.00K 10-Q/A · filed 2024-11-18 | $1.49M derived: sum of 3 quarters · filed 2025-03-14 | $728.00K derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2023-03-31 | $4.81M 10-Q/A · filed 2024-11-18 | $59.00K 10-Q · filed 2023-05-02 | $6.15M derived: sum of 2 quarters · filed 2025-03-14 | $5.39M derived: sum of 3 quarters · filed 2025-03-14 | $6.01M derived: sum of 4 quarters · filed 2025-03-14 | ||
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | $574.00K derived: sum of 2 quarters · filed 2025-03-14 | $1.20M derived: sum of 3 quarters · filed 2025-03-14 | $966.00K 10-K · filed 2025-03-14 | |||
| 2022-09-30 | -$764.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$142.00K derived: sum of 2 quarters · filed 2024-11-18 | -$372.00K 10-Q/A · filed 2024-11-18 | -$180.00K derived: sum of 4 quarters · filed 2024-11-18 | |||
| 2022-06-30 | $622.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $392.00K 10-Q/A · filed 2024-11-18 | $584.00K derived: sum of 3 quarters · filed 2024-11-18 | $623.00K derived: sum of 4 quarters · filed 2024-11-18 | |||
| 2022-03-31 | -$230.00K 10-Q/A · filed 2024-11-18 | -$247.00K 10-Q · filed 2022-04-27 | -$38.00K derived: sum of 2 quarters · filed 2024-11-18 | $1.00K derived: sum of 3 quarters · filed 2024-11-18 | -$1.12M derived: sum of 4 quarters · filed 2024-11-18 | ||
| 2021-12-31 | $192.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $231.00K derived: sum of 2 quarters · filed 2024-11-18 | -$891.00K derived: sum of 3 quarters · filed 2024-11-18 | -$1.42M 10-K/A · filed 2024-11-18 | |||
| 2021-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$1.08M derived: sum of 2 quarters · filed 2022-11-01 | -$1.62M 10-Q · filed 2022-11-01 | -$1.59M 10-Q · filed 2021-10-28 | -$3.72M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$1.66M 10-Q · filed 2022-08-02 | -$1.79M 10-Q · filed 2021-07-27 | -$3.76M derived: sum of 3 quarters · filed 2023-02-22 | -$2.98M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-31 | -$533.00K 10-Q · filed 2022-04-27 | -$2.63M derived: sum of 2 quarters · filed 2023-02-22 | -$1.86M derived: sum of 3 quarters · filed 2023-02-22 | $396.00K derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$1.33M derived: sum of 2 quarters · filed 2023-02-22 | $929.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.11M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $773.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $3.03M derived: sum of 2 quarters · filed 2021-10-28 | $3.21M 10-Q · filed 2021-10-28 | $1.47M 10-Q · filed 2020-11-05 | -$7.38M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $2.44M 10-Q · filed 2021-07-27 | $897.00K 10-Q · filed 2020-07-30 | -$8.15M derived: sum of 3 quarters · filed 2022-02-17 | $2.43M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-03-31 | $180.00K 10-Q · filed 2021-05-04 | -$10.41M derived: sum of 2 quarters · filed 2022-02-17 | $169.00K derived: sum of 3 quarters · filed 2022-02-17 | $167.00K derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2019-12-31 | -$10.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$11.00K derived: sum of 2 quarters · filed 2022-02-17 | -$13.00K derived: sum of 3 quarters · filed 2022-02-17 | -$19.00K 10-K · filed 2022-02-17 | |||
| 2019-09-30 | $10.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.57M derived: sum of 2 quarters · filed 2020-11-05 | $10.57M 10-Q · filed 2020-11-05 | $9.99M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$8.00K 10-Q · filed 2020-07-30 | -$589.00K derived: sum of 3 quarters · filed 2021-02-24 | -$545.00K derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | -$6.00K 10-Q · filed 2020-05-06 | -$587.00K derived: sum of 2 quarters · filed 2021-02-24 | -$543.00K derived: sum of 3 quarters · filed 2021-02-24 | -$497.00K derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | -$581.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$537.00K derived: sum of 2 quarters · filed 2021-02-24 | -$491.00K derived: sum of 3 quarters · filed 2021-02-24 | -$494.00K 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $90.00K derived: sum of 2 quarters · filed 2019-10-31 | $87.00K 10-Q · filed 2019-10-31 | $869.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $43.00K 10-Q · filed 2019-08-01 | $825.00K derived: sum of 3 quarters · filed 2020-02-26 | $740.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | -$3.00K 10-Q · filed 2019-05-09 | $779.00K derived: sum of 2 quarters · filed 2020-02-26 | $694.00K derived: sum of 3 quarters · filed 2020-02-26 | $651.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $697.00K derived: sum of 2 quarters · filed 2020-02-26 | $654.00K derived: sum of 3 quarters · filed 2020-02-26 | $611.00K 10-K · filed 2020-02-26 | |||
| 2017-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$128.00K derived: sum of 2 quarters · filed 2018-11-01 | -$171.00K 10-Q · filed 2018-11-01 | ||||
| 2017-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$86.00K 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | -$43.00K 10-Q · filed 2018-05-08 | ||||||
| 2016-12-31 | -$240.00K 10-K · filed 2019-03-01 | ||||||
| 2015-12-31 | $2.12M 10-K · filed 2018-02-22 | ||||||
| 2015-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$425.41K 10-Q · filed 2015-08-06 | -$1.21M derived: sum of 3 quarters · filed 2015-08-06 | -$1.25M derived: sum of 4 quarters · filed 2015-08-06 | |||
| 2015-03-31 | -$2.51M 10-Q · filed 2015-05-08 | -$3.29M derived: sum of 2 quarters · filed 2015-05-08 | -$3.34M derived: sum of 3 quarters · filed 2015-05-08 | -$3.44M derived: sum of 4 quarters · filed 2015-08-06 | |||
| 2014-12-31 | -$781.50K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | -$828.69K derived: sum of 2 quarters · filed 2015-03-17 | -$929.87K derived: sum of 3 quarters · filed 2015-08-06 | -$1.04M 10-K · filed 2015-03-17 | |||
| 2014-09-30 | -$47.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$148.37K derived: sum of 2 quarters · filed 2015-08-06 | -$254.59K 10-Q · filed 2014-11-07 | $456.81K derived: sum of 4 quarters · filed 2015-08-06 | |||
| 2014-06-30 | -$101.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$207.39K 10-Q · filed 2015-08-06 | $504.00K derived: sum of 3 quarters · filed 2015-08-06 | ||||
| 2014-03-31 | -$106.22K 10-Q · filed 2015-05-08 | $605.18K derived: sum of 2 quarters · filed 2015-05-08 | |||||
| 2013-12-31 | $711.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $1.20M 10-K · filed 2015-03-17 | |||||
| 2013-09-30 | $490.27K 10-Q · filed 2014-11-07 | ||||||
| 2012-12-31 | -$1.11M 10-K · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |